1 citations
,
July 2023 in “Al-Azhar Medical Journal” This study observed a significant association between antigliadin antibodies (IgA and IgG) and alopecia areata severity, suggesting that serological tests could help diagnose subclinical celiac disease in these patients, with IgA and IgG showing 100% sensitivity and specificity at specific cutoff points.
January 2022 in “Al-Azhar Medical Journal” This study found a significant association between antigliadin antibodies (IgA and IgG) and alopecia areata severity, suggesting a need for celiac disease screening in these patients.
July 2026 in “World Journal of Advanced Research and Reviews” In this report, an 80-year-old male with elevated serum IgG4 presented with a lesion suggestive of IgG4-related ophthalmic disease, but lack of orbital imaging and biopsy precluded definitive diagnosis, highlighting the necessity of excluding similar conditions before long-term treatment.
January 2026 in “Journal of Cutaneous Immunology and Allergy” In this case report, a young Japanese man was diagnosed with scalp IgG4-related disease, which mimicked acne keloidalis nuchae but was identified by histopathology and elevated serum IgG4 levels as a systemic fibroinflammatory disorder, highlighting the importance of differential diagnosis in atypical scarring alopecia.
July 2025 in “Chinese Journal of Dermatology” This study reported differences in serum IgG N-glycans between male patients with different types of androgenetic alopecia, suggesting that GP10 and GP22 may serve as biomarkers for assessing hair loss severity in male FPHL.